Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 71101 - 71125 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	IFNGR1	3459	downregulated	Silicon Dioxide results in decreased expression of IFNGR1 mRNA	6q23.3	A24196
Silicon dioxide	Approved	IFRD1	3475	upregulated	Silicon Dioxide analog results in increased expression of IFRD1 mRNA	7q31.1	A24195
Silicon dioxide	Approved	IFRD1	3475	downregulated	Silicon Dioxide results in decreased expression of IFRD1 mRNA	7q31.1	A24196
Silicon dioxide	Approved	IFT140	9742	downregulated	Silicon Dioxide analog results in decreased expression of IFT140 mRNA	16p13.3	A24195
Silicon dioxide	Approved	IGDCC4	57722	upregulated	Silicon Dioxide analog results in increased expression of IGDCC4 mRNA	15q22.31	A24195
Silicon dioxide	Approved	IGF2	3481	downregulated	Silicon Dioxide analog results in decreased expression of IGF2 mRNA	11p15.5	A24195
Silicon dioxide	Approved	IGFBP1	3484	upregulated	Silicon Dioxide analog results in increased expression of IGFBP1 mRNA	7p12.3	A24195
Silicon dioxide	Approved	IGFBP2	3485	upregulated	Silicon Dioxide analog results in increased expression of IGFBP2 mRNA	2q35	A24194
Silicon dioxide	Approved	IGFBP3	3486	downregulated	Silicon Dioxide analog results in decreased expression of IGFBP3 mRNA	7p12.3	A24195
Silicon dioxide	Approved	IGFBP3	3486	upregulated	Silicon Dioxide results in increased expression of IGFBP3 mRNA	7p12.3	A24196
Silicon dioxide	Approved	IGFBP5	3488	downregulated	Silicon Dioxide analog results in decreased expression of IGFBP5 mRNA	2q35	A24195
Silicon dioxide	Approved	IGFBP6	3489	downregulated	Silicon Dioxide analog results in decreased expression of IGFBP6 mRNA	12q13.13	A24194
Silicon dioxide	Approved	IGIP	492311	downregulated	Silicon Dioxide analog results in decreased expression of IGIP mRNA	5q31.3	A24195
Silicon dioxide	Approved	IGSF10	285313	downregulated	Silicon Dioxide analog results in decreased expression of IGSF10 mRNA	3q25.1	A24195
Silicon dioxide	Approved	IGSF11	152404	downregulated	Silicon Dioxide analog results in decreased expression of IGSF11 mRNA	3q13.32	A24195
Silicon dioxide	Approved	IL10RA	3587	upregulated	Silicon Dioxide analog results in increased expression of IL10RA mRNA	11q23.3	A24195
Silicon dioxide	Approved	IL11	3589	upregulated	Silicon Dioxide analog results in increased expression of IL11 mRNA	19q13.42	A24194
Silicon dioxide	Approved	IL11RA	3590	downregulated	Silicon Dioxide analog results in decreased expression of IL11RA mRNA	9p13.3	A24195
Silicon dioxide	Approved	IL13	3596	upregulated	Silicon Dioxide results in increased expression of IL13 mRNA	5q31.1	A24205
Silicon dioxide	Approved	IL13RA2	3598	upregulated	Silicon Dioxide analog results in increased expression of IL13RA2 mRNA	Xq23	A24194
Silicon dioxide	Approved	IL13RA2	3598	upregulated	Silicon Dioxide results in increased expression of IL13RA2 mRNA	Xq23	A24196
Silicon dioxide	Approved	IL15	3600	upregulated	Silicon Dioxide analog results in increased expression of IL15 mRNA	4q31.21	A24194
Silicon dioxide	Approved	IL16	3603	upregulated	Silicon Dioxide analog results in increased expression of IL16 mRNA	15q25.1	A24195
Silicon dioxide	Approved	IL16	3603	upregulated	Silicon Dioxide results in increased expression of IL16 mRNA	15q25.1	A24196
Silicon dioxide	Approved	IL17B	27190	downregulated	Silicon Dioxide analog results in decreased expression of IL17B mRNA	5q32	A24195

Displaying entries 71101 - 71125 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability